Charles River Laboratories International (CRL) Interest & Investment Income (2009 - 2025)

Charles River Laboratories International's Interest & Investment Income history runs 17 years deep, the most recent figure standing at $1.0 million for Q4 2025.

• In Q4 2025, Interest & Investment Income fell 44.58% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $4.9 million (down 42.39% YoY), while the FY2025 annual figure was $4.9 million, down 42.39% from the prior year.
• Interest & Investment Income was $1.0 million for Q4 2025 at Charles River Laboratories International, down from $1.4 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.0 million in Q2 2024 to a low of $35000.0 in Q1 2021.
• Historically, Interest & Investment Income has averaged $1.0 million across 5 years, with a median of $1.1 million in 2025.
• The sharpest annual moves came in 2021 and 2023: Interest & Investment Income sank 88.92% in 2021, then jumped 1025.41% in 2023.
• A 5-year view of Interest & Investment Income shows it stood at $309000.0 in 2021, then gained by 11.0% to $343000.0 in 2022, then jumped by 363.85% to $1.6 million in 2023, then climbed by 15.34% to $1.8 million in 2024, then sank by 44.58% to $1.0 million in 2025.
• The last three Interest & Investment Income figures came in at $1.0 million (Q4 2025), $1.4 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.